LINDSEY GARRISON: Open Payments
NPI 1316291610 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 22 payments from 13 companies in 2025. Trend: 2023 $866 · 2024 $635 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| Lundbeck LLC | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Globus Medical, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
Products named: HYQVIA, Belbuca, XTAMPZA, VYEPTI, INGREZZA, ETERNA, RELISTOR, Senza.
Industry payments across GA — which companies pay providers there.
